Quick Answer
MUSTANG BIO, INC. reported Stockholders Equity of $9.53 million for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +346.0% in Stockholders Equity from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $3.32 million | Q1 2017: $74.21 million | Q2 2017: $69.07 million | Q3 2017: $65.09 million | Q1 2018: $55.64 million | Q2 2018: $51.61 million | Q3 2018: $44.99 million | Q1 2019: $28.48 million | Q2 2019: $71.44 million | Q3 2019: $62.45 million | Q1 2020: $45.80 million | Q2 2020: $71.03 million | Q3 2020: $76.42 million | Q1 2021: $133.36 million | Q2 2021: $135.03 million | Q3 2021: $122.21 million | Q1 2022: $97.33 million | Q2 2022: $82.01 million | Q3 2022: $64.33 million | Q1 2023: $29.82 million | Q2 2023: $13.71 million | Q3 2023: $4.01 million | Q1 2024: -$4.94 million | Q2 2024: -$8.33 million | Q3 2024: -$8.66 million | Q1 2025: $3.61 million | Q2 2025: $2.89 million | Q3 2025: $9.77 million.
- Over the full 11 years of available data (2015 to 2025), MUSTANG BIO, INC.'s Stockholders Equity has grown by 330.8%.
- Historical annual values: Fiscal year 2025: $9.53 million | Fiscal year 2024: -$3.87 million | Fiscal year 2023: $123.0 thousand | Fiscal year 2022: $46.27 million | Fiscal year 2021: $112.40 million | Fiscal year 2020: $98.44 million | Fiscal year 2019: $51.65 million | Fiscal year 2018: $36.40 million | Fiscal year 2017: $59.83 million | Fiscal year 2016: $24.28 million | Fiscal year 2015: -$4.13 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: